Medicinal product name Anagrelide Mylan
Pharmaceutical form Capsule, hard
Strength 0.5 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/17/1256/001 KZSRN100 Is available
Legal status Rx Prescription (Pr.)
KZSR Reimbursed medicines reference product
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresVēstule veselības aprūpes speciālistam Vēstule veselības aprūpes speciālistam
ATC code L01XX35 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(29 containers)
Tamro, Recipe Plus, Magnum Medical N100
(0,5 mg)
HDPE bottle 170.05 
KZSR*
EU/1/17/1256/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/17/1256/001
Date of authorisation Feb 15, 2018
Marketing authorisation holder, country Mylan Pharmaceuticals Limited, Ireland